BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25833829)

  • 1. PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.
    Bonastre E; Verdura S; Zondervan I; Facchinetti F; Lantuejoul S; Chiara MD; Rodrigo JP; Carretero J; Condom E; Vidal A; Sidransky D; Villanueva A; Roz L; Brambilla E; Savola S; Sanchez-Cespedes M
    Cancer Res; 2015 Apr; 75(7):1287-97. PubMed ID: 25833829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.
    Zhou Q; Dai J; Chen T; Dada LA; Zhang X; Zhang W; DeCamp MM; Winn RA; Sznajder JI; Zhou G
    Cell Signal; 2017 Oct; 38():49-59. PubMed ID: 28652146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma.
    Zen K; Yasui K; Gen Y; Dohi O; Wakabayashi N; Mitsufuji S; Itoh Y; Zen Y; Nakanuma Y; Taniwaki M; Okanoue T; Yoshikawa T
    Oncogene; 2009 Aug; 28(32):2910-8. PubMed ID: 19503097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell adhesion and polarity in squamous cell carcinoma of the lung.
    Bonastre E; Brambilla E; Sanchez-Cespedes M
    J Pathol; 2016 Apr; 238(5):606-16. PubMed ID: 26749265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Par3 promotes lung adenocarcinoma metastasis through 14-3-3ζ protein.
    Song T; Tian X; Kai F; Ke J; Wei Z; Jing-Song L; Si-Hua W; Jian-Jun W
    Oncotarget; 2016 Sep; 7(39):64260-64273. PubMed ID: 27588399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis.
    Wang S; Cai J; Zhang S; Dong M; Zhang L; Xu Y; Shen B; Chen S
    Cancer Sci; 2021 Jul; 112(7):2625-2641. PubMed ID: 33931921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare Deleterious PARD3 Variants in the aPKC-Binding Region are Implicated in the Pathogenesis of Human Cranial Neural Tube Defects Via Disrupting Apical Tight Junction Formation.
    Chen X; An Y; Gao Y; Guo L; Rui L; Xie H; Sun M; Lam Hung S; Sheng X; Zou J; Bao Y; Guan H; Niu B; Li Z; Finnell RH; Gusella JF; Wu BL; Zhang T
    Hum Mutat; 2017 Apr; 38(4):378-389. PubMed ID: 27925688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
    Achiwa H; Lazo JS
    Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling.
    Koh W; Mahan RD; Davis GE
    J Cell Sci; 2008 Apr; 121(Pt 7):989-1001. PubMed ID: 18319301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
    Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
    Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
    Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
    Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells.
    Kwei KA; Finch JS; Ranger-Moore J; Bowden GT
    Cancer Lett; 2006 Jan; 231(2):326-38. PubMed ID: 15893875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.
    Vallath S; Sage EK; Kolluri KK; Lourenco SN; Teixeira VS; Chimalapati S; George PJ; Janes SM; Giangreco A
    Sci Rep; 2016 Apr; 6():24006. PubMed ID: 27035095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
    Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis.
    McCaffrey LM; Montalbano J; Mihai C; Macara IG
    Cancer Cell; 2012 Nov; 22(5):601-14. PubMed ID: 23153534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.
    Man K; Ng KT; Lo CM; Ho JW; Sun BS; Sun CK; Lee TK; Poon RT; Fan ST
    Liver Transpl; 2007 Dec; 13(12):1669-77. PubMed ID: 18044786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.
    Wang Z; Zhu S; Shen M; Liu J; Wang M; Li C; Wang Y; Deng A; Mei Q
    Carcinogenesis; 2013 Mar; 34(3):678-88. PubMed ID: 23172665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Coronin-1C disrupts Rac1 activation and impairs tumorigenic potential in hepatocellular carcinoma cells.
    Wang ZG; Jia MK; Cao H; Bian P; Fang XD
    Oncol Rep; 2013 Mar; 29(3):1066-72. PubMed ID: 23292607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.